Resistance to inhibitors of the human immunodeficiency virus type 1 integration
Braz. j. infect. dis
;
14(5): 513-518, Sept.-Oct. 2010. ilus
Article
in English
| LILACS
| ID: lil-570569
ABSTRACT
This review will summarize the role of integrase in HIV-1 infection, the mechanism of integrase inhibitors and resistance with an emphasis on raltegravir (RAL), the first integrase inhibitor licensed to treat HIV-1 infection.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
HIV Infections
/
HIV-1
/
Virus Integration
/
HIV Integrase Inhibitors
/
HIV Integrase
/
Drug Resistance, Viral
Limits:
Humans
Language:
English
Journal:
Braz. j. infect. dis
Journal subject:
Communicable Diseases
Year:
2010
Type:
Article
Similar
MEDLINE
...
LILACS
LIS